2006 EUROPEAN SOCIETY FOR MEDICAL DECISION MAKING MEETING
Identifieur interne : 005080 ( Main/Merge ); précédent : 005079; suivant : 0050812006 EUROPEAN SOCIETY FOR MEDICAL DECISION MAKING MEETING
Auteurs :Source :
- Medical Decision Making [ 0272-989X ] ; 2007-07.
English descriptors
- Teeft :
- 2department, 2imperial college, 2university, Abstracts conclusions, Abstracts methods, Abstracts purpose, Abstracts results, Actual decision, Acute infrarenal, Additional language versions, Alternative approach, Alternative screening strategies, Amsterdam, Analogue, Anchor state, Anesthetist, Annual health care expenditures, Antihypertensive medication, Appropriate diagnoses, Aqlq scores, Artery disease, Asthma, Asthma control, Asthma quality, Aston university, Asymmetry, Atrial fibrillation, Australia purpose, Autonomous decision, Available evidence, Barthel index, Baseline, Bayesian, Bayesian approach, Better asthma control, Better decisions, Bias, Bias term, Biennial european meeting, Biosource corporation, Birth weight, Blood pressure, Bootstrap approach, Breast cancer, Budget impact analysis, Canada purpose, Cancer, Cancer screening, Cardiovascular, Cardiovascular disease, Cardiovascular events, Carlo, Case study, Cdss, Center rotterdam, Centre, Cervical screening states, Characteristic curve, Chemotherapy, Child characteristics, Childhood asthma, Chlamydia, Chlamydia prevalence, Chlamydia screening, Chlamydia screening studies, Chlamydial infection, Choice experiments, Chronic disease management, Chronic diseases, Chronic illness, Chronic kidney disease, Clinical decisions, Clinical guidelines, Clinical outcome, Clinical outcomes, Clinical practice, Clinical prediction rule, Clinical stage, Clinical studies, Clinical trial data, Clinical trials, Clinical validity, Clinician, Coefficient, Cognitive, Cognitive process model, Cohort, Cohort model, Colorectal cancer, Common comparator, Common diseases, Competitive athletes, Complex task, Confidence intervals, Confidentiality, Confounder selection, Congestive heart failure, Consultation time, Content analysis, Context independence, Control group, Convergent validity, Coronary artery disease, Cost effectiveness, Cost estimates, Costeffectiveness analysis, Critical event, Cue, Current practice, Data collection, Database, Decision analysis, Decision makers, Decision paths, Decision process, Decision rules, Decision strategies, Decision support system, Decision tree, Decision trees, Decisionmaking, Denmark purpose, Depressed patients, Depressive patients, Diabetes, Diabetes management, Diagnostic accuracy, Diagnostic costs, Diagnostic decision, Diagnostic odds ratio, Diagnostic performance, Different approaches, Different causes, Different interview formats, Different results, Different risk formats, Different screening strategies, Different strategies, Different techniques, Differential diagnoses, Discrete event simulation, Discriminative ability, Disease management programs, Disease prognosis, Disease progression, Drug users, Dutch tariff, Dynamic model, East lansing, Ecological criterion, Economic appraisal, Economic appraisals, Economic data, Economic evaluation, Economic evaluations, Economics unit, Ectopic pregnancy, Edmunds, Effect size, Electronic databases, Elicitation, Emergency department, Emergency room visits, Endometrial cancer, Endoscopy, Endovascular, Endovascular repair, Eq5d, Eq5d domains, Eq5d tariffs, Erasmus, Eskd, Eskd patients, Ethical decision, Ethical principles, Everyday life, Exfoliation glaucoma, Expert panel, Expert policy, Extensive decision, Family history, Final model, First questionnaire, Focus group interviews, Framing effects, Framing treatment benefits, France purpose, Freiburg, Full information, Further information, Further research, General population, General practitioners, Genetic algorithms, Genetic counselling, Genetic testing, Glaucoma, Good location, Groningen, Group differences, Guideline, Hall austria purpose, Health care, Health care expenditures, Health economics, Health economics facility, Health outcomes, Health professionals, Health protection agency, Health risk information, Health sciences, Health sector, Health services, Health state, Health state descriptions, Health state valuation techniques, Health state valuations, Health states, Health technology assessment, Herd immunity, Heterogeneity, Home haemodialysis, Hormone therapy, Hospitalisation, Hrhpv, Hrhpv knowledge, Illicit drug, Illness management, Immunisation, Important role, Inadequate treatment, Incident data, Inclusion criteria, Incremental, Incremental cost, Incremental costs, Incremental ratio, Indirect costs, Indirect effects, Individualized quality, Indolent cancer, Influence diagram, Influenza, Influenza vaccination, Information requirements, Information search, Information visualisation, Insurance premiums, International health, International survey, Internet panel, Intervention group, Iqwig, James university hospital, Judgement, Judgement performance, Kidney check australia taskforce, Kidney disease, Kidney health australia, Kidney transplant, Kingdom purpose, Knowledge errors, Language therapists, Language versions, Large number, Large rearrangements, Latanoprost, Leiden, Leiden university, Life extension, Life utilities, Life weights, Life year, Life years, Little evidence, Local search methods, Logistic regression, Lower levels, Lung cancer, Maastricht university, Managerial decisions, Manchester triage system, Markov, Markov approach, Markov model, Markov models, Mathematical model, Maximum number, Medical decision, Medical decisions, Medical informatics, Medical literature, Medical technology assessment, Medication, Mental health professionals, Methodology, Model results, Model stewart stewart passmore, Modeling, Modeling uncertainty, Modelling, Monte carlo sampling, Morbidity, More accuracy, Mortality rates, Multiple objectives, Multivariable model, Mutation, National patient safety agency, Netherlands, Netherlands purpose, Norway, Norway purpose, Norwegian knowledge centre, Norwich university hospital, Novice, Nurse performance, Obese patients, Occupational health, Older patients, Older people, Oncologist, Open angle glaucoma, Open repair, Open surgery, Opportunistic, Opportunistic chlamydia screening, Opportunistic screening, Option, Organisational benefits, Other health professionals, Other measures, Outcome measures, Ovarian, Ovarian cancer, Ovarian cancer patients, Overall survival, Paediatric emergency care, Pandemic, Parameter values, Partner notification, Passive immunisation, Patient consultations, Patient involvement, Patient outcomes, Patient participation, Patient preferences, Patient safety, Payer perspective, Performance instructions, Perinatal period, Peritoneal dialysis, Person trade, Personal risk, Pharmaceutical product, Pharmaceutical research network, Pictorial representation, Plot asymmetry, Pneumococcal, Pneumococcal conjugate vaccine, Pneumococcal disease, Pneumonia, Policy makers, Population screening, Positive aspects, Positive family history, Positive prediction value, Possible reasons, Practitioner, Preference, Preferred information format, Pregnant women, Preliminary analyses, Preliminary analysis, Preliminary results, Prenatal, Prenatal screening, Present study, Prevalence, Preventive behaviour, Previous pandemics, Primary care, Prince alfred hospital, Prison reception, Prison vaccination, Process information, Production rules, Programme, Progression, Prolabels database, Prostaglandin analogs, Prostate, Prostate cancer, Proxy outcome measures, Psychological distress, Psychometric properties, Psychometric validation, Public health, Public health interventions, Publication bias, Qaly, Qalys, Radboud university nijmegen, Radiation dose, Radiographic pneumonia, Random sample, Randomised, Rasch analysis, Reasoning biases, Reference case, Regression analysis, Regression model, Relative risk reduction, Relative treatment effects, Reliability, Renal, Renal replacement therapy, Respiratory morbidity, Respiratory tract infections, Respiratory tract symptoms, Results show, Rheumatoid arthritis, Risk assessment, Risk factors, Risk information, Risk perception, Risk status, Rotavirus, Rotterdam, Routine vaccination, Same comparison, Scenario, Screening, Screening program, Screening strategies, Screening test, Seasonal month, Sensitivity analyses, Sensitivity analysis, Sequela, Severe side effects, Severe uncertainty, Sheffield, Side effects, Significant correlations, Significant impact, Significant reductions, Significant variation, Similar analyses, Simulation, Situation awareness, Smaller studies, Social decision, Social medicine, Societal perspective, Socioeconomic status, Southern denmark, Stage kidney disease, Standard approach, Standard gamble, Statistical modelling, Structural equation modelling, Subjective norm, Substitute preferences, Support decision, Support patients, Survival studies, Survival trials, Switzerland purpose, Symptom, Syndrome, Systematic review, Systematic reviews, Test characteristics, Test evaluation program, Test recommendation, Thematic content analysis, Time horizon, Time points, Time trade, Timolol maleate, Total elimination, Trading decision, Transition probabilities, Transmission dynamics, Transplant, Transplant registry, Treatment adherence, Treatment choices, Treatment decision, Treatment decisionmaking, Treatment effect, Treatment effects, Treatment options, Treatment questionnaire, Trial conditions, Trial participation, Unidimensional scale, Unit costs, University hospital, Unrealistic optimism, Unrealistic pessimism, Urinary symptoms, Useful tool, Usual activities, Utility estimates, Utility scores, Utility values, Utility weights, Vaccination, Vaccine, Validation, Variance, Verbal screening, Visual acuity, Visual analogue scale, Website, Weight change, Weighting, Wider economy, Young people, Zealand dialysis.
Url:
DOI: 10.1177/0272989X080270040104
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002538
- to stream Istex, to step Curation: 002538
- to stream Istex, to step Checkpoint: 001680
Links to Exploration step
ISTEX:525CB0AB84383F0EC9BA6467590F85311F2844B5Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">2006 EUROPEAN SOCIETY FOR MEDICAL DECISION MAKING MEETING</title>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:525CB0AB84383F0EC9BA6467590F85311F2844B5</idno>
<date when="2007" year="2007">2007</date>
<idno type="doi">10.1177/0272989X080270040104</idno>
<idno type="url">https://api.istex.fr/ark:/67375/M70-DPPD2M40-0/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002538</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002538</idno>
<idno type="wicri:Area/Istex/Curation">002538</idno>
<idno type="wicri:Area/Istex/Checkpoint">001680</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001680</idno>
<idno type="wicri:Area/Main/Merge">005080</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">2006 EUROPEAN SOCIETY FOR MEDICAL DECISION MAKING MEETING</title>
</analytic>
<monogr></monogr>
<series><title level="j">Medical Decision Making</title>
<idno type="ISSN">0272-989X</idno>
<idno type="eISSN">1552-681X</idno>
<imprint><publisher>Sage Publications</publisher>
<pubPlace>Sage CA: Los Angeles, CA</pubPlace>
<date type="published" when="2007-07">2007-07</date>
<biblScope unit="volume">27</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="page" from="-3">e-3</biblScope>
<biblScope unit="page" to="-4">e-4</biblScope>
</imprint>
<idno type="ISSN">0272-989X</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0272-989X</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>2department</term>
<term>2imperial college</term>
<term>2university</term>
<term>Abstracts conclusions</term>
<term>Abstracts methods</term>
<term>Abstracts purpose</term>
<term>Abstracts results</term>
<term>Actual decision</term>
<term>Acute infrarenal</term>
<term>Additional language versions</term>
<term>Alternative approach</term>
<term>Alternative screening strategies</term>
<term>Amsterdam</term>
<term>Analogue</term>
<term>Anchor state</term>
<term>Anesthetist</term>
<term>Annual health care expenditures</term>
<term>Antihypertensive medication</term>
<term>Appropriate diagnoses</term>
<term>Aqlq scores</term>
<term>Artery disease</term>
<term>Asthma</term>
<term>Asthma control</term>
<term>Asthma quality</term>
<term>Aston university</term>
<term>Asymmetry</term>
<term>Atrial fibrillation</term>
<term>Australia purpose</term>
<term>Autonomous decision</term>
<term>Available evidence</term>
<term>Barthel index</term>
<term>Baseline</term>
<term>Bayesian</term>
<term>Bayesian approach</term>
<term>Better asthma control</term>
<term>Better decisions</term>
<term>Bias</term>
<term>Bias term</term>
<term>Biennial european meeting</term>
<term>Biosource corporation</term>
<term>Birth weight</term>
<term>Blood pressure</term>
<term>Bootstrap approach</term>
<term>Breast cancer</term>
<term>Budget impact analysis</term>
<term>Canada purpose</term>
<term>Cancer</term>
<term>Cancer screening</term>
<term>Cardiovascular</term>
<term>Cardiovascular disease</term>
<term>Cardiovascular events</term>
<term>Carlo</term>
<term>Case study</term>
<term>Cdss</term>
<term>Center rotterdam</term>
<term>Centre</term>
<term>Cervical screening states</term>
<term>Characteristic curve</term>
<term>Chemotherapy</term>
<term>Child characteristics</term>
<term>Childhood asthma</term>
<term>Chlamydia</term>
<term>Chlamydia prevalence</term>
<term>Chlamydia screening</term>
<term>Chlamydia screening studies</term>
<term>Chlamydial infection</term>
<term>Choice experiments</term>
<term>Chronic disease management</term>
<term>Chronic diseases</term>
<term>Chronic illness</term>
<term>Chronic kidney disease</term>
<term>Clinical decisions</term>
<term>Clinical guidelines</term>
<term>Clinical outcome</term>
<term>Clinical outcomes</term>
<term>Clinical practice</term>
<term>Clinical prediction rule</term>
<term>Clinical stage</term>
<term>Clinical studies</term>
<term>Clinical trial data</term>
<term>Clinical trials</term>
<term>Clinical validity</term>
<term>Clinician</term>
<term>Coefficient</term>
<term>Cognitive</term>
<term>Cognitive process model</term>
<term>Cohort</term>
<term>Cohort model</term>
<term>Colorectal cancer</term>
<term>Common comparator</term>
<term>Common diseases</term>
<term>Competitive athletes</term>
<term>Complex task</term>
<term>Confidence intervals</term>
<term>Confidentiality</term>
<term>Confounder selection</term>
<term>Congestive heart failure</term>
<term>Consultation time</term>
<term>Content analysis</term>
<term>Context independence</term>
<term>Control group</term>
<term>Convergent validity</term>
<term>Coronary artery disease</term>
<term>Cost effectiveness</term>
<term>Cost estimates</term>
<term>Costeffectiveness analysis</term>
<term>Critical event</term>
<term>Cue</term>
<term>Current practice</term>
<term>Data collection</term>
<term>Database</term>
<term>Decision analysis</term>
<term>Decision makers</term>
<term>Decision paths</term>
<term>Decision process</term>
<term>Decision rules</term>
<term>Decision strategies</term>
<term>Decision support system</term>
<term>Decision tree</term>
<term>Decision trees</term>
<term>Decisionmaking</term>
<term>Denmark purpose</term>
<term>Depressed patients</term>
<term>Depressive patients</term>
<term>Diabetes</term>
<term>Diabetes management</term>
<term>Diagnostic accuracy</term>
<term>Diagnostic costs</term>
<term>Diagnostic decision</term>
<term>Diagnostic odds ratio</term>
<term>Diagnostic performance</term>
<term>Different approaches</term>
<term>Different causes</term>
<term>Different interview formats</term>
<term>Different results</term>
<term>Different risk formats</term>
<term>Different screening strategies</term>
<term>Different strategies</term>
<term>Different techniques</term>
<term>Differential diagnoses</term>
<term>Discrete event simulation</term>
<term>Discriminative ability</term>
<term>Disease management programs</term>
<term>Disease prognosis</term>
<term>Disease progression</term>
<term>Drug users</term>
<term>Dutch tariff</term>
<term>Dynamic model</term>
<term>East lansing</term>
<term>Ecological criterion</term>
<term>Economic appraisal</term>
<term>Economic appraisals</term>
<term>Economic data</term>
<term>Economic evaluation</term>
<term>Economic evaluations</term>
<term>Economics unit</term>
<term>Ectopic pregnancy</term>
<term>Edmunds</term>
<term>Effect size</term>
<term>Electronic databases</term>
<term>Elicitation</term>
<term>Emergency department</term>
<term>Emergency room visits</term>
<term>Endometrial cancer</term>
<term>Endoscopy</term>
<term>Endovascular</term>
<term>Endovascular repair</term>
<term>Eq5d</term>
<term>Eq5d domains</term>
<term>Eq5d tariffs</term>
<term>Erasmus</term>
<term>Eskd</term>
<term>Eskd patients</term>
<term>Ethical decision</term>
<term>Ethical principles</term>
<term>Everyday life</term>
<term>Exfoliation glaucoma</term>
<term>Expert panel</term>
<term>Expert policy</term>
<term>Extensive decision</term>
<term>Family history</term>
<term>Final model</term>
<term>First questionnaire</term>
<term>Focus group interviews</term>
<term>Framing effects</term>
<term>Framing treatment benefits</term>
<term>France purpose</term>
<term>Freiburg</term>
<term>Full information</term>
<term>Further information</term>
<term>Further research</term>
<term>General population</term>
<term>General practitioners</term>
<term>Genetic algorithms</term>
<term>Genetic counselling</term>
<term>Genetic testing</term>
<term>Glaucoma</term>
<term>Good location</term>
<term>Groningen</term>
<term>Group differences</term>
<term>Guideline</term>
<term>Hall austria purpose</term>
<term>Health care</term>
<term>Health care expenditures</term>
<term>Health economics</term>
<term>Health economics facility</term>
<term>Health outcomes</term>
<term>Health professionals</term>
<term>Health protection agency</term>
<term>Health risk information</term>
<term>Health sciences</term>
<term>Health sector</term>
<term>Health services</term>
<term>Health state</term>
<term>Health state descriptions</term>
<term>Health state valuation techniques</term>
<term>Health state valuations</term>
<term>Health states</term>
<term>Health technology assessment</term>
<term>Herd immunity</term>
<term>Heterogeneity</term>
<term>Home haemodialysis</term>
<term>Hormone therapy</term>
<term>Hospitalisation</term>
<term>Hrhpv</term>
<term>Hrhpv knowledge</term>
<term>Illicit drug</term>
<term>Illness management</term>
<term>Immunisation</term>
<term>Important role</term>
<term>Inadequate treatment</term>
<term>Incident data</term>
<term>Inclusion criteria</term>
<term>Incremental</term>
<term>Incremental cost</term>
<term>Incremental costs</term>
<term>Incremental ratio</term>
<term>Indirect costs</term>
<term>Indirect effects</term>
<term>Individualized quality</term>
<term>Indolent cancer</term>
<term>Influence diagram</term>
<term>Influenza</term>
<term>Influenza vaccination</term>
<term>Information requirements</term>
<term>Information search</term>
<term>Information visualisation</term>
<term>Insurance premiums</term>
<term>International health</term>
<term>International survey</term>
<term>Internet panel</term>
<term>Intervention group</term>
<term>Iqwig</term>
<term>James university hospital</term>
<term>Judgement</term>
<term>Judgement performance</term>
<term>Kidney check australia taskforce</term>
<term>Kidney disease</term>
<term>Kidney health australia</term>
<term>Kidney transplant</term>
<term>Kingdom purpose</term>
<term>Knowledge errors</term>
<term>Language therapists</term>
<term>Language versions</term>
<term>Large number</term>
<term>Large rearrangements</term>
<term>Latanoprost</term>
<term>Leiden</term>
<term>Leiden university</term>
<term>Life extension</term>
<term>Life utilities</term>
<term>Life weights</term>
<term>Life year</term>
<term>Life years</term>
<term>Little evidence</term>
<term>Local search methods</term>
<term>Logistic regression</term>
<term>Lower levels</term>
<term>Lung cancer</term>
<term>Maastricht university</term>
<term>Managerial decisions</term>
<term>Manchester triage system</term>
<term>Markov</term>
<term>Markov approach</term>
<term>Markov model</term>
<term>Markov models</term>
<term>Mathematical model</term>
<term>Maximum number</term>
<term>Medical decision</term>
<term>Medical decisions</term>
<term>Medical informatics</term>
<term>Medical literature</term>
<term>Medical technology assessment</term>
<term>Medication</term>
<term>Mental health professionals</term>
<term>Methodology</term>
<term>Model results</term>
<term>Model stewart stewart passmore</term>
<term>Modeling</term>
<term>Modeling uncertainty</term>
<term>Modelling</term>
<term>Monte carlo sampling</term>
<term>Morbidity</term>
<term>More accuracy</term>
<term>Mortality rates</term>
<term>Multiple objectives</term>
<term>Multivariable model</term>
<term>Mutation</term>
<term>National patient safety agency</term>
<term>Netherlands</term>
<term>Netherlands purpose</term>
<term>Norway</term>
<term>Norway purpose</term>
<term>Norwegian knowledge centre</term>
<term>Norwich university hospital</term>
<term>Novice</term>
<term>Nurse performance</term>
<term>Obese patients</term>
<term>Occupational health</term>
<term>Older patients</term>
<term>Older people</term>
<term>Oncologist</term>
<term>Open angle glaucoma</term>
<term>Open repair</term>
<term>Open surgery</term>
<term>Opportunistic</term>
<term>Opportunistic chlamydia screening</term>
<term>Opportunistic screening</term>
<term>Option</term>
<term>Organisational benefits</term>
<term>Other health professionals</term>
<term>Other measures</term>
<term>Outcome measures</term>
<term>Ovarian</term>
<term>Ovarian cancer</term>
<term>Ovarian cancer patients</term>
<term>Overall survival</term>
<term>Paediatric emergency care</term>
<term>Pandemic</term>
<term>Parameter values</term>
<term>Partner notification</term>
<term>Passive immunisation</term>
<term>Patient consultations</term>
<term>Patient involvement</term>
<term>Patient outcomes</term>
<term>Patient participation</term>
<term>Patient preferences</term>
<term>Patient safety</term>
<term>Payer perspective</term>
<term>Performance instructions</term>
<term>Perinatal period</term>
<term>Peritoneal dialysis</term>
<term>Person trade</term>
<term>Personal risk</term>
<term>Pharmaceutical product</term>
<term>Pharmaceutical research network</term>
<term>Pictorial representation</term>
<term>Plot asymmetry</term>
<term>Pneumococcal</term>
<term>Pneumococcal conjugate vaccine</term>
<term>Pneumococcal disease</term>
<term>Pneumonia</term>
<term>Policy makers</term>
<term>Population screening</term>
<term>Positive aspects</term>
<term>Positive family history</term>
<term>Positive prediction value</term>
<term>Possible reasons</term>
<term>Practitioner</term>
<term>Preference</term>
<term>Preferred information format</term>
<term>Pregnant women</term>
<term>Preliminary analyses</term>
<term>Preliminary analysis</term>
<term>Preliminary results</term>
<term>Prenatal</term>
<term>Prenatal screening</term>
<term>Present study</term>
<term>Prevalence</term>
<term>Preventive behaviour</term>
<term>Previous pandemics</term>
<term>Primary care</term>
<term>Prince alfred hospital</term>
<term>Prison reception</term>
<term>Prison vaccination</term>
<term>Process information</term>
<term>Production rules</term>
<term>Programme</term>
<term>Progression</term>
<term>Prolabels database</term>
<term>Prostaglandin analogs</term>
<term>Prostate</term>
<term>Prostate cancer</term>
<term>Proxy outcome measures</term>
<term>Psychological distress</term>
<term>Psychometric properties</term>
<term>Psychometric validation</term>
<term>Public health</term>
<term>Public health interventions</term>
<term>Publication bias</term>
<term>Qaly</term>
<term>Qalys</term>
<term>Radboud university nijmegen</term>
<term>Radiation dose</term>
<term>Radiographic pneumonia</term>
<term>Random sample</term>
<term>Randomised</term>
<term>Rasch analysis</term>
<term>Reasoning biases</term>
<term>Reference case</term>
<term>Regression analysis</term>
<term>Regression model</term>
<term>Relative risk reduction</term>
<term>Relative treatment effects</term>
<term>Reliability</term>
<term>Renal</term>
<term>Renal replacement therapy</term>
<term>Respiratory morbidity</term>
<term>Respiratory tract infections</term>
<term>Respiratory tract symptoms</term>
<term>Results show</term>
<term>Rheumatoid arthritis</term>
<term>Risk assessment</term>
<term>Risk factors</term>
<term>Risk information</term>
<term>Risk perception</term>
<term>Risk status</term>
<term>Rotavirus</term>
<term>Rotterdam</term>
<term>Routine vaccination</term>
<term>Same comparison</term>
<term>Scenario</term>
<term>Screening</term>
<term>Screening program</term>
<term>Screening strategies</term>
<term>Screening test</term>
<term>Seasonal month</term>
<term>Sensitivity analyses</term>
<term>Sensitivity analysis</term>
<term>Sequela</term>
<term>Severe side effects</term>
<term>Severe uncertainty</term>
<term>Sheffield</term>
<term>Side effects</term>
<term>Significant correlations</term>
<term>Significant impact</term>
<term>Significant reductions</term>
<term>Significant variation</term>
<term>Similar analyses</term>
<term>Simulation</term>
<term>Situation awareness</term>
<term>Smaller studies</term>
<term>Social decision</term>
<term>Social medicine</term>
<term>Societal perspective</term>
<term>Socioeconomic status</term>
<term>Southern denmark</term>
<term>Stage kidney disease</term>
<term>Standard approach</term>
<term>Standard gamble</term>
<term>Statistical modelling</term>
<term>Structural equation modelling</term>
<term>Subjective norm</term>
<term>Substitute preferences</term>
<term>Support decision</term>
<term>Support patients</term>
<term>Survival studies</term>
<term>Survival trials</term>
<term>Switzerland purpose</term>
<term>Symptom</term>
<term>Syndrome</term>
<term>Systematic review</term>
<term>Systematic reviews</term>
<term>Test characteristics</term>
<term>Test evaluation program</term>
<term>Test recommendation</term>
<term>Thematic content analysis</term>
<term>Time horizon</term>
<term>Time points</term>
<term>Time trade</term>
<term>Timolol maleate</term>
<term>Total elimination</term>
<term>Trading decision</term>
<term>Transition probabilities</term>
<term>Transmission dynamics</term>
<term>Transplant</term>
<term>Transplant registry</term>
<term>Treatment adherence</term>
<term>Treatment choices</term>
<term>Treatment decision</term>
<term>Treatment decisionmaking</term>
<term>Treatment effect</term>
<term>Treatment effects</term>
<term>Treatment options</term>
<term>Treatment questionnaire</term>
<term>Trial conditions</term>
<term>Trial participation</term>
<term>Unidimensional scale</term>
<term>Unit costs</term>
<term>University hospital</term>
<term>Unrealistic optimism</term>
<term>Unrealistic pessimism</term>
<term>Urinary symptoms</term>
<term>Useful tool</term>
<term>Usual activities</term>
<term>Utility estimates</term>
<term>Utility scores</term>
<term>Utility values</term>
<term>Utility weights</term>
<term>Vaccination</term>
<term>Vaccine</term>
<term>Validation</term>
<term>Variance</term>
<term>Verbal screening</term>
<term>Visual acuity</term>
<term>Visual analogue scale</term>
<term>Website</term>
<term>Weight change</term>
<term>Weighting</term>
<term>Wider economy</term>
<term>Young people</term>
<term>Zealand dialysis</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005080 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 005080 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= PandemieGrippaleV1 |flux= Main |étape= Merge |type= RBID |clé= ISTEX:525CB0AB84383F0EC9BA6467590F85311F2844B5 |texte= 2006 EUROPEAN SOCIETY FOR MEDICAL DECISION MAKING MEETING }}
This area was generated with Dilib version V0.6.34. |